IRIS
MARTINI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.268
NA - Nord America 1.497
AS - Asia 1.311
SA - Sud America 240
Continente sconosciuto - Info sul continente non disponibili 62
AF - Africa 34
OC - Oceania 5
Totale 6.417
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 1.626
US - Stati Uniti d'America 1.413
RU - Federazione Russa 977
CN - Cina 368
SG - Singapore 362
BR - Brasile 193
SE - Svezia 148
HK - Hong Kong 143
NL - Olanda 135
JP - Giappone 112
VN - Vietnam 107
DE - Germania 85
FR - Francia 69
BD - Bangladesh 60
IN - India 57
CA - Canada 48
GB - Regno Unito 46
FI - Finlandia 39
TR - Turchia 35
MX - Messico 24
ES - Italia 23
PL - Polonia 21
AT - Austria 17
AR - Argentina 15
IQ - Iraq 12
LT - Lituania 11
ZA - Sudafrica 11
CH - Svizzera 9
CO - Colombia 9
CZ - Repubblica Ceca 9
UA - Ucraina 9
ID - Indonesia 8
IE - Irlanda 7
NO - Norvegia 6
PT - Portogallo 6
CL - Cile 5
DK - Danimarca 5
EC - Ecuador 5
MA - Marocco 5
NG - Nigeria 5
PE - Perù 5
PK - Pakistan 5
AU - Australia 4
BG - Bulgaria 4
DZ - Algeria 4
GR - Grecia 4
IL - Israele 4
PH - Filippine 4
UZ - Uzbekistan 4
VE - Venezuela 4
BE - Belgio 3
EG - Egitto 3
HN - Honduras 3
NP - Nepal 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BO - Bolivia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
IR - Iran 2
JO - Giordania 2
KR - Corea 2
KZ - Kazakistan 2
MY - Malesia 2
OM - Oman 2
RO - Romania 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
CY - Cipro 1
ET - Etiopia 1
HR - Croazia 1
HU - Ungheria 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PY - Paraguay 1
UY - Uruguay 1
Totale 6.355
Salva come PNG Salva come JPEG
Città #
Ashburn 268
Milan 263
Singapore 200
Moscow 173
Dallas 156
Rome 141
Hong Kong 139
San Jose 130
New York 93
Shanghai 73
Beijing 64
Council Bluffs 59
Los Angeles 52
Turin 46
Hefei 42
Verona 38
Boardman 36
Bologna 35
Munich 35
Florence 34
Lauterbourg 34
Ho Chi Minh City 33
Tokyo 32
Lawrence 28
Princeton 28
Santa Clara 28
Genoa 24
Hanoi 24
Orem 23
São Paulo 23
Bari 21
Pune 21
Brooklyn 20
Helsinki 20
Palermo 19
Montreal 18
Frankfurt am Main 17
Catania 14
Denver 14
Naples 14
Warsaw 14
Amsterdam 13
Chennai 13
Chicago 13
Phoenix 13
Turku 12
Atlanta 11
Azzano San Paolo 11
Bolzano 11
Da Nang 10
Mexico City 10
The Dalles 10
Toronto 10
Trieste 10
Brescia 9
Manchester 9
Paris 9
Vienna 9
Columbus 8
Houston 8
Modena 8
Ankara 7
Bergamo 7
Bursa 7
Cascina 7
Dublin 7
Guangzhou 7
Johannesburg 7
Lamezia Terme 7
London 7
Mumbai 7
Nuremberg 7
Padova 7
Perugia 7
Porto Alegre 7
Prato 7
Haiphong 6
Hayamiya 6
Istanbul 6
Miami 6
Montepulciano 6
Parma 6
Pesaro 6
Poplar 6
Rio de Janeiro 6
Seattle 6
Stockholm 6
Treviso 6
Venice 6
Andria 5
Erbil 5
Falconara Marittima 5
Omaha 5
Pavia 5
Pisa 5
Reggio Emilia 5
Arcore 4
Bar Harbor 4
Barnet 4
Brasília 4
Totale 2.987
Salva come PNG Salva come JPEG
Nome #
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 2.092
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 173
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 163
Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis 148
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis 142
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 142
How to Select the Optimal Candidates for Renal Mass Biopsy 134
Contemporary Techniques of Prostate Dissection for Robot-assisted Prostatectomy 133
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 128
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence 127
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 126
Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell Cancer 124
Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors 124
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 122
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 119
Immunotherapy in advanced kidney cancer: an alternative meta-analytic method using reconstructed survival data in case of proportional hazard assumption violation 112
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy 111
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 111
Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial 107
Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysis 105
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer 102
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy 101
Neoadjuvant and adjuvant immunotherapy in renal cell carcinoma 101
Estimated Costs Associated With Radiation Therapy for Positive Surgical Margins During Radical Prostatectomy 97
Citrullination licenses calpain to decondense nuclei in neutrophil extracellular trap formation 96
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) 96
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 96
Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution 95
The obesity paradox in metastatic castration-resistant prostate cancer 94
Re: Evaluation of Cause of Death after Radical Cystectomy for Patients with Bladder Cancer: The Impact of Age at the Time of Surgery 91
Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy 90
A Plea for Economically Sustainable Evidence-based Guidelines 90
Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration 87
Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma 81
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer 80
Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI 70
Metastatic hormone‑sensitive prostate cancer: local treatment strategies 66
UltraPulse Carbon Dioxide Laser Plus Methyl Aminolevulinate-Photodynamic Therapy for the Treatment of Penile Cancer 62
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study 57
RE: Validating the Martini Staging System for Rectourethral Fistula: A Meta-analysis of Postoperative Outcomes 57
Unexpected Outcomes of Renal Function after Radical Nephrectomy: Histology Relevance along with Clinical Aspects 55
Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy 53
Time-dependent recovery of brain hypometabolism in neuro-COVID-19 patients 52
Surgical repair of post-cesarean vesicouterine fistula: A systematic review and a plea for prevention 4
null 1
Totale 6.417
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.136
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.136
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022109 0 9 1 18 7 6 14 11 5 9 17 12
2022/2023385 74 60 28 21 21 58 27 41 20 5 18 12
2023/2024751 18 21 31 50 53 133 41 156 12 60 71 105
2024/20251.478 163 64 128 75 87 124 202 164 189 97 74 111
2025/20263.347 243 198 192 422 305 119 270 277 836 193 101 191
2026/2027335 235 100 0 0 0 0 0 0 0 0 0 0
Totale 6.417